Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Mar 23;131(22):2466–2474. doi: 10.1182/blood-2017-11-815506

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by The American Society of Hematology

PMC Copyright notice

Figure 4. — Effects of MP dose adjustments on active metabolite DNA-TG accumulation in vivo. (A) Mice received daily MP injections at 4 different doe levels, and DNA-TG was measured in bone marrow mononucleated cells on day 5. At each dosage level, 8 mice of each genotype were included. (B) In 95 children with ALL, DNA-TG was monitored longitudinally during MP dosage titration. In both mice and patients, trend lines were established to describe the relationship of MP dosage with DNA-TG, using Michaelis-Menten kinetics model. Shades indicate 95% confidence intervals of the model.